AAA

Affinity Asset Advisors Portfolio holdings

AUM $1.39B
1-Year Est. Return 230.19%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+230.19%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.39B
AUM Growth
+$317M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
118
New
Increased
Reduced
Closed

Top Buys

1
+$34.5M
2
+$28M
3
+$19.1M
4
ROIV icon
Roivant Sciences
ROIV
+$17.8M
5
FBRX icon
Forte Biosciences
FBRX
+$17.3M

Top Sells

1
+$66.7M
2
+$56.3M
3
+$42.8M
4
MRUS
Merus
MRUS
+$26.9M
5
SLNO icon
Soleno Therapeutics
SLNO
+$13.5M

Sector Composition

1 Healthcare 96.69%
2 Financials 0.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TSHA icon
26
Taysha Gene Therapies
TSHA
$1.85B
$18.1M 1.3%
3,300,000
+300,000
MDGL icon
27
Madrigal Pharmaceuticals
MDGL
$12.2B
$18.1M 1.3%
31,131
-83,869
SVRA icon
28
Savara
SVRA
$1.18B
$16.9M 1.21%
2,797,153
+1,297,153
PTGX icon
29
Protagonist Therapeutics
PTGX
$6.76B
$15M 1.08%
172,125
-48,475
CNTA
30
Centessa Pharmaceuticals
CNTA
$6.13B
$15M 1.08%
600,552
-506,610
ESTA icon
31
Establishment Labs
ESTA
$1.97B
$14.6M 1.05%
200,000
-110,000
ERAS icon
32
Erasca
ERAS
$5.91B
$14.5M 1.04%
3,900,000
-385,787
VERA icon
33
Vera Therapeutics
VERA
$3.03B
$12.7M 0.91%
250,000
-53,330
COGT icon
34
Cogent Biosciences
COGT
$6.05B
$12.4M 0.89%
+350,000
OVID icon
35
Ovid Therapeutics
OVID
$439M
$11.7M 0.84%
7,150,000
+4,500,000
TVTX icon
36
Travere Therapeutics
TVTX
$3.77B
$11.5M 0.82%
300,000
-200,000
JBIO
37
Jade Biosciences
JBIO
$1.13B
$11M 0.79%
714,956
+649,639
NAMS icon
38
NewAmsterdam Pharma
NAMS
$3.99B
$9.65M 0.69%
275,000
CLDX icon
39
Celldex Therapeutics
CLDX
$2.71B
$9.51M 0.68%
350,000
+50,000
ZURA icon
40
Zura Bio
ZURA
$551M
$9.5M 0.68%
1,813,671
+539,320
TNGX icon
41
Tango Therapeutics
TNGX
$3.8B
$8.86M 0.64%
+1,000,000
STRO icon
42
Sutro Biopharma
STRO
$523M
$8.66M 0.62%
748,382
+673,110
RVMD icon
43
Revolution Medicines
RVMD
$31B
$7.96M 0.57%
100,000
MBX
44
MBX Biosciences
MBX
$1.6B
$7.88M 0.57%
250,000
+85,000
VRDN icon
45
Viridian Therapeutics
VRDN
$1.51B
$7.78M 0.56%
250,000
RCUS icon
46
Arcus Biosciences
RCUS
$3.04B
$7.15M 0.51%
+300,000
SGMT icon
47
Sagimet Biosciences
SGMT
$211M
$6.8M 0.49%
1,148,245
+798,245
KPTI icon
48
Karyopharm Therapeutics
KPTI
$194M
$6.55M 0.47%
+889,575
ASND icon
49
Ascendis Pharma
ASND
$15B
$6.4M 0.46%
+30,000
VRCA icon
50
Verrica Pharmaceuticals
VRCA
$109M
$5.88M 0.42%
+707,338
1
2
3 4 5